AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Journal of Neurorestoratology Article
PDF (137.6 KB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Case Series | Open Access

Chromaffin cell transplantation for neuropathic pain after spinal cord injury: a report of two cases

Lin Chen1,2, Haitao Xi1, Juan Xiao1, Feng Zhang1, Di Chen1, Hongyun Huang1,3( )
Cell Therapy Center, Beijing Hongtianji Neuroscience Academy,
Department of Neurosurgery, Tsinghua University Yuquan Hospital,
Neurorestoratology Institute, General Hospital of Chinese People’s Armed Police Forces, Beijing, People’s Republic of China
Show Author Information

Abstract

Neuropathic pain (NP), a common secondary complication following spinal cord injury (SCI), presenting at or below the level of injury is largely refractory to current pharmacological, physical, and surgical treatments. Previous studies have demonstrated the promising value of cell therapy including adrenal chromaffin cells that have the capacity to act as mini-pumps that release amines and peptides for alleviating chronic pain. The paper presents the cases of two gentlemen suffering from severe central NP after thoracic SCI. Six months after chromaffin cell intrathecal injection, their pain relieved significantly. The results demonstrated the preliminary therapeutic efficacy of chromaffin cell transplants in people with NP, and support further research of this treatment strategy for the management of intractable chronic pain due to SCI.

Keywords

chromaffin cellcell transplantationneuropathic painspinal cord injury

References

1.
Daszkiewicz A, Gierlotka Z, Nierodziński W, Misiołek A, Misiołek H. Neuropathic pain after spinal cord injury resistant to conventional therapies - case report. Psychiatr Pol. 2016;50(2):345-355.
Crossref Google Scholar
2.
Nardone R, Höller Y, Langthaler PB, et al. rTMS of the prefrontal cortex has analgesic effects on neuropathic pain in subjects with spinal cord injury. Spinal Cord. Epub 2016 May 31.
Google Scholar
3.
Gwak YS, Kim HY, Lee BH, Yang CH. Combined approaches for the relief of spinal cord injury-induced neuropathic pain. Complement Ther Med. 2016;25:27-33.
Crossref Google Scholar
4.
Chen L, Huang H, Sharma HS, Zuo H, Sanberg P. Cell transplantation as a pain therapy targets both analgesia and neural repair. Cell Transplant. 2013;22(Suppl 1):S11-S19.
Crossref Google Scholar
5.
Huang H, Chen L, Sanberg P. Cell therapy from bench to bedside translation in CNS neurorestoratology era. Cell Med. 2010;1(1):15-46.
Crossref Google Scholar
6.
Huang H, Sun T, Chen L, et al. Consensus of clinical neurorestorative progress in patients with complete chronic spinal cord injury. Cell Transplant. 2014;23(Suppl 1):S5-S17.
Crossref Google Scholar
7.
Huang HY, Mao GS, Chen L, Liu AB. Progress and challenges with clinical cell therapy in neurorestoratology. J Neurorestoratology. 2015;3:91-95.
Crossref Google Scholar
8.
Yousefifard M, Nasirinezhad F, Shardi Manaheji H, Janzadeh A, Hosseini M, Keshavarz M. Human bone marrow-derived and umbilical cord-derived mesenchymal stem cells for alleviating neuropathic pain in a spinal cord injury model. Stem Cell Res Ther .2016;7:36.
Crossref Google Scholar
9.
Watanabe S, Uchida K, Nakajima H, et al. Early transplantation of mesenchymal stem cells after spinal cord injury relieves pain hypersensitivity through suppression of pain-related signaling cascades and reduced inflammatory cell recruitment. Stem Cells. 2015;33(6):1902-1914.
Crossref Google Scholar
10.
Hwang I, Hahm SC, Choi KA, et al. Intrathecal transplantation of embryonic stem cell-derived spinal GABAergic neural precursor cells attenuates neuropathic pain in a spinal cord injury rat model. Cell Transplant. 2016;25(3):593-607.
Crossref Google Scholar
11.
Ambriz-Tututi M1, Monjaraz-Fuentes F, Drucker-Colín R. Chromaffin cell transplants: from the lab to the clinic. Life Sci. 2012;91(25-26):1243-1251.
Crossref Google Scholar
12.
Bourdel N, Alves J, Pickering G, Ramilo I, Roman H, Canis M. Systematic review of endometriosis pain assessment: how to choose a scale? Hum Reprod Update. 2015;21(1):136-152.
Crossref Google Scholar
13.
Huang H, Xi H, Chen L, Zhang F, Liu Y. Long-term outcome of olfactory ensheathing cell therapy for patients with complete chronic spinal cord injury. Cell Transplant. 2012;21(Suppl 1):S23-S31.
Crossref Google Scholar
14.
Burke D, Fullen BM, Stokes D, Lennon O. Neuropathic pain prevalence following spinal cord injury: a systematic review and meta-analysis. Eur J Pain. Epub 2016 Jun 24.
Google Scholar
15.
Jang JY, Lee SH, Kim M, Ryu JS. Characteristics of neuropathic pain in patients with spinal cord injury. Ann Rehabil Med. 2014;38(3):327-334.
Crossref Google Scholar
16.
Jutzeler CR, Huber E, Callaghan MF, et al. Association of pain and CNS structural changes after spinal cord injury. Sci Rep. 2016;6:18534.
Crossref Google Scholar
17.
Detloff MR, Quiros-Molina D, Javia AS, et al. Delayed exercise is ineffective at reversing aberrant nociceptive afferent plasticity or neuropathic pain after spinal cord injury in rats. Neurorehabil Neural Repair. 2016;30(7):685-700.
Crossref Google Scholar
18.
Mehta S, McIntyre A, Janzen S, Loh E, Teasell R; Spinal Cord Injury Rehabilitation Evidence Team. Systematic review of pharmacological treatments of pain after spinal cord injury: an update. Arch Phys Med Rehabil. 2016;97(8):1381-1392.
Crossref Google Scholar
19.
Siddall PJ, Middleton JW. Spinal cord injury-induced pain: mechanisms and treatments. Pain Manag. 2015;5(6):493-507.
Crossref Google Scholar
20.
Lazorthes Y, Sagen J, Sallerin B, et al. Human chromaffin cell graft into the CSF for cancer pain management: a prospective phase II clinical study. Pain. 2000;87(1):19-32.
Crossref Google Scholar
21.
Jozan S, Aziza J, Châtelin S, et al. Human fetal chromaffin cells: a potential tool for cell pain therapy. Exp Neurol. 2007;205(2):525-535.
Crossref Google Scholar
22.
Pappas GD. Fine structure of host-graft relationships between transplanted chromaffin cells and CNS. FASEB J. 1999;13(Suppl 2):S277-S280.
Crossref Google Scholar
23.
Bés JC, Tkaczuk J, Czech KA, et al. One-year chromaffin cell allograft survival in cancer patients with chronic pain: morphological and functional evidence. Cell Transplant. 1998;7(3):227-238.
Crossref Google Scholar
24.
Brewer KL, Yezierski RP. Effects of adrenal medullary transplants on pain-related behaviors following excitotoxic spinal cord injury. Brain Res. 1998;798(1-2):83-92.
Crossref Google Scholar
Journal of Neurorestoratology
Volume 5 Issue 1,
December 2017
Pages 47-50
DOI: 10.2147/JN.S120173
Cite this article:
Chen L, Xi H, Xiao J, et al. Chromaffin cell transplantation for neuropathic pain after spinal cord injury: a report of two cases. Journal of Neurorestoratology, 2017, 5(1): 47-50. https://doi.org/10.2147/JN.S120173

426

Views

14

Downloads

3

Crossref

1

Web of Science

0

Scopus

Altmetrics
Published: 13 February 2017
© 2017 The Author(s).

© 2017 Chen et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
Return